UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Clinical trials for UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Freeze-and-Heat attack: could a new device boost liver cancer treatment?
Disease control Not yet recruitingThis study tests whether adding a special thermal therapy (which freezes and heats tumors) to standard targeted therapy and immunotherapy can help people with advanced liver cancer that cannot be removed by surgery. About 166 participants will be randomly assigned to receive eith…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New trial matches liver cancer treatment to Tumor's Fat-Burning signature
Disease control Not yet recruitingThis phase II trial tests a personalized approach for people with advanced liver cancer that cannot be removed by surgery. Researchers will classify each patient's tumor by its fatty acid degradation (FAD) subtype and assign either a drug combination (camrelizumab plus apatinib) …
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC